PortfoliosLab logoPortfoliosLab logo
ATAI vs. PG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ATAI vs. PG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Atai Life Sciences N.V. (ATAI) and The Procter & Gamble Company (PG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ATAI achieves a -4.16% return, which is significantly lower than PG's 5.93% return.


ATAI

1D
3.16%
1M
-2.97%
YTD
-4.16%
6M
-8.62%
1Y
85.78%
3Y*
29.14%
5Y*
10Y*

PG

1D
0.86%
1M
4.83%
YTD
5.93%
6M
6.28%
1Y
-3.97%
3Y*
3.69%
5Y*
4.73%
10Y*
8.96%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ATAI vs. PG - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ATAI
Atai Life Sciences N.V.
-4.16%207.52%-5.67%-46.99%-65.14%-63.67%
PG
The Procter & Gamble Company
5.93%-12.26%17.25%-0.86%-5.05%23.61%

Correlation

The correlation between ATAI and PG is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.01

Correlation (All Time)
Calculated using the full available price history since Jun 18, 2021

0.04

Fundamentals

Market Cap

ATAI:

$1.40B

PG:

$361.53B

EPS

ATAI:

-$2.67

PG:

$5.23

PS Ratio

ATAI:

279.18

PG:

4.20

PB Ratio

ATAI:

7.05

PG:

6.70

Total Revenue (TTM)

ATAI:

$3.49M

PG:

$86.72B

Gross Profit (TTM)

ATAI:

$3.49M

PG:

$43.64B

EBITDA (TTM)

ATAI:

-$663.38M

PG:

$22.63B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ATAI vs. PG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATAI
ATAI Risk / Return Rank: 7272
Overall Rank
ATAI Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
ATAI Sortino Ratio Rank: 7575
Sortino Ratio Rank
ATAI Omega Ratio Rank: 7373
Omega Ratio Rank
ATAI Calmar Ratio Rank: 7373
Calmar Ratio Rank
ATAI Martin Ratio Rank: 6767
Martin Ratio Rank

PG
PG Risk / Return Rank: 2828
Overall Rank
PG Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
PG Sortino Ratio Rank: 2525
Sortino Ratio Rank
PG Omega Ratio Rank: 2626
Omega Ratio Rank
PG Calmar Ratio Rank: 3131
Calmar Ratio Rank
PG Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATAI vs. PG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ATAIPGDifference
Sharpe ratioReturn per unit of total volatility

+1.29

Sortino ratioReturn per unit of downside risk

+2.19

Omega ratioGain probability vs. loss probability

1.23

0.97

+0.27

Calmar ratioReturn relative to maximum drawdown

1.67

-0.37

+2.04

Martin ratioReturn relative to average drawdown

2.66

-0.68

+3.34

ATAI vs. PG - Sharpe Ratio Comparison

The current ATAI Sharpe Ratio is 0.99, which is higher than the PG Sharpe Ratio of -0.30. The chart below compares the historical Sharpe Ratios of ATAI and PG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ATAI vs. PG - Drawdown Comparison

The maximum ATAI drawdown since its inception was -95.05%, which is greater than PG's maximum drawdown of -54.25%. Use the drawdown chart below to compare losses from any high point for ATAI and PG.


Loading charts...

Drawdown Indicators


ATAIPGDifference

Max Drawdown

Largest peak-to-trough decline

-95.05%

-54.25%

-40.80%

Max Drawdown (1Y)

Largest decline over 1 year

-48.06%

-15.52%

-32.54%

Max Drawdown (3Y)

Largest decline over 3 years

-59.23%

-21.15%

-38.08%

Max Drawdown (5Y)

Largest decline over 5 years

-23.77%

Max Drawdown (10Y)

Largest decline over 10 years

-23.77%

Current Drawdown

Current decline from peak

-81.33%

-13.29%

-68.04%

Average Drawdown

Average peak-to-trough decline

-80.78%

-12.16%

-68.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.10%

8.80%

+21.30%

Volatility

ATAI vs. PG - Volatility Comparison

Atai Life Sciences N.V. (ATAI) has a higher volatility of 20.22% compared to The Procter & Gamble Company (PG) at 6.99%. This indicates that ATAI's price experiences larger fluctuations and is considered to be riskier than PG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ATAIPGDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.22%

6.99%

+13.23%

Volatility (6M)

Calculated over the trailing 6-month period

50.17%

15.01%

+35.16%

Volatility (1Y)

Calculated over the trailing 1-year period

81.21%

18.78%

+62.43%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

83.71%

17.82%

+65.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

83.71%

19.05%

+64.66%

Dividends

ATAI vs. PG - Dividend Comparison

ATAI has not paid dividends to shareholders, while PG's dividend yield for the trailing twelve months is around 2.85%.


PositionTTM20252024202320222021202020192018201720162015
ATAI
Atai Life Sciences N.V.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PG
The Procter & Gamble Company
2.85%2.91%2.36%2.55%2.38%2.08%2.24%2.37%3.09%2.98%3.18%3.31%

Financials

ATAI vs. PG - Financials Comparison

This section allows you to compare key financial metrics between Atai Life Sciences N.V. and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
954.00K
21.24B
(ATAI) Total Revenue
(PG) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ATAI and PG have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ATAI has higher volatility (20.22%) compared to PG (6.99%). In terms of maximum drawdown, ATAI dropped -95.05% vs PG's -54.25%.

ATAI currently has the higher Sharpe Ratio (0.99 vs -0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ATAI and PG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer